Syn2bio S.A. (WSE:S2B)

Market Cap	287.54M
Revenue	n/a
Net Income	n/a
EPS	n/a
Shares Out	8.73M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	19,031
Open	32.80
Previous Close	32.65
Day's Range	32.02 - 34.00
52-Week Range	26.20 - 47.40
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 25, 2026

About Syn2bio

Syn2bio S.A., a biotechnology company, engages in the research and commercialization of Cardiac Marker, a radiopharmaceutical for diagnostic testing of heart disease in the field of myocardial perfusion. The company’s flagship project is the cardiotracer project, a radiopharmaceutical designed for testing myocardial perfusion and diagnosis of coronary artery disease. Additionally, it operates The Centre for Research on New Compounds, a unit engaged in the search for new pharmaceutical compounds and their further study, registration, and market ...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2025
• Country: Poland
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: S2B